Camouflage and misdirection: The full-on assault of ebola virus disease

Cell

Volumn 159, Issue 3, 2014, Pages 477-486

  Misasi, John ^a   Sullivan, Nancy J ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; HUMORAL ANTIBODY; INTERFERON; CYTOKINE; VIRAL PROTEIN;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; ANTIVIRAL ACTIVITY; B LYMPHOCYTE; CYTOKINE STORM; EBOLA VIRUS; HEMORRHAGIC FEVER; HUMAN; IMMUNE DYSREGULATION; NONHUMAN; PROTEIN INTERACTION; REVIEW; RNA INTERFERENCE; RNA STABILITY; T LYMPHOCYTE; VIRUS REPLICATION; EBOLA HEMORRHAGIC FEVER; EBOLAVIRUS; HUMORAL IMMUNITY; IMMUNE EVASION; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; VIROLOGY; VIRUS ENTRY;

CYTOKINES; EBOLAVIRUS; HEMORRHAGIC FEVER, EBOLA; IMMUNE EVASION; IMMUNE TOLERANCE; IMMUNITY, HUMORAL; VIRAL PROTEINS; VIRUS INTERNALIZATION;

EID: 84908312337     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2014.10.006     Document Type: Review

References (121)

1. P. Aleksandrowicz, A. Marzi, N. Biedenkopf, N. Beimforde, S. Becker, T. Hoenen, H. Feldmann, and H.-J. Schnittler Ebola virus enters host cells by macropinocytosis and clathrin-mediated endocytosis J. Infect. Dis. 204 Suppl 3 2011 S957 S967
2. C.P. Alvarez, F. Lasala, J. Carrillo, O. Muñiz, A.L. Corbí, and R. Delgado C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans J. Virol. 76 2002 6841 6844
3. S. Amini-Bavil-Olyaee, Y.J.J. Choi, J.H.H. Lee, M. Shi, I.-C. Huang, M. Farzan, and J.U.U. Jung The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry Cell Host Microbe 13 2013 452 464
4. S. Baize, E.M. Leroy, M.C. Georges-Courbot, M. Capron, J. Lansoud-Soukate, P. Debré, S.P. Fisher-Hoch, J.B. McCormick, and A.J. Georges Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients Nat. Med. 5 1999 423 426
5. S. Baize, E.M. Leroy, A.J. Georges, M.C. Georges-Courbot, M. Capron, I. Bedjabaga, J. Lansoud-Soukate, and E. Mavoungou Inflammatory responses in Ebola virus-infected patients Clin. Exp. Immunol. 128 2002 163 168
6. F. Baribaud, S. Pöhlmann, G. Leslie, F. Mortari, and R.W. Doms Quantitative expression and virus transmission analysis of DC-SIGN on monocyte-derived dendritic cells J. Virol. 76 2002 9135 9142
7. C.F. Basler, X. Wang, E. Mühlberger, V. Volchkov, J. Paragas, H.D. Klenk, A. García-Sastre, and P. Palese The Ebola virus VP35 protein functions as a type I IFN antagonist Proc. Natl. Acad. Sci. USA 97 2000 12289 12294
8. C.F. Basler, A. Mikulasova, L. Martinez-Sobrido, J. Paragas, E. Mühlberger, M. Bray, H.-D. Klenk, P. Palese, and A. García-Sastre The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3 J. Virol. 77 2003 7945 7956
9. T.A. Bharat, T. Noda, J.D. Riches, V. Kraehling, L. Kolesnikova, S. Becker, Y. Kawaoka, and J.A. Briggs Structural dissection of Ebola virus and its assembly determinants using cryo-electron tomography Proc. Natl. Acad. Sci. USA 109 2012 4275 4280
10. N. Biedenkopf, B. Hartlieb, T. Hoenen, and S. Becker Phosphorylation of Ebola virus VP30 influences the composition of the viral nucleocapsid complex: impact on viral transcription and replication J. Biol. Chem. 288 2013 11165 11174
11. M. Biermann, C. Maueröder, J.M. Brauner, R. Chaurio, C. Janko, M. Herrmann, and L.E. Muñoz Surface code - biophysical signals for apoptotic cell clearance Phys. Biol. 10 2013 065007
12. M. Brecher, K.L. Schornberg, S.E. Delos, M.L. Fusco, E.O. Saphire, and J.M. White Cathepsin cleavage potentiates the Ebola virus glycoprotein to undergo a subsequent fusion-relevant conformational change J. Virol. 86 2012 364 372
13. M.A. Brindley, C.L. Hunt, A.S. Kondratowicz, J. Bowman, P.L. Sinn, P.B. McCray Jr., K. Quinn, M.L. Weller, J.A. Chiorini, and W. Maury Tyrosine kinase receptor Axl enhances entry of Zaire ebolavirus without direct interactions with the viral glycoprotein Virology 415 2011 83 94
14. J.E. Brunner, J.H.C. Nguyen, H.H. Roehl, T.V. Ho, K.M. Swiderek, and B.L. Semler Functional interaction of heterogeneous nuclear ribonucleoprotein C with poliovirus RNA synthesis initiation complexes J. Virol. 79 2005 3254 3266
15. J.E. Brunner, K.J. Ertel, J.M. Rozovics, and B.L. Semler Delayed kinetics of poliovirus RNA synthesis in a human cell line with reduced levels of hnRNP C proteins Virology 400 2010 240 247
16. W.B. Cárdenas, Y.-M. Loo, M. Gale Jr., A.L. Hartman, C.R. Kimberlin, L. Martínez-Sobrido, E.O. Saphire, and C.F. Basler Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling J. Virol. 80 2006 5168 5178
17. J.E. Carette, M. Raaben, A.C. Wong, A.S. Herbert, G. Obernosterer, N. Mulherkar, A.I. Kuehne, P.J. Kranzusch, A.M. Griffin, and G. Ruthel Ebola virus entry requires the cholesterol transporter Niemann-Pick C1 Nature 477 2011 340 343
18. K. Chandran, N.J. Sullivan, U. Felbor, S.P. Whelan, and J.M. Cunningham Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection Science 308 2005 1643 1645
19. T.-H. Chang, T. Kubota, M. Matsuoka, S. Jones, S.B. Bradfute, M. Bray, and K. Ozato Ebola Zaire virus blocks type I interferon production by exploiting the host SUMO modification machinery PLoS Pathog. 5 2009 e1000493
20. H. Cheon, and G.R. Stark Unphosphorylated STAT1 prolongs the expression of interferon-induced immune regulatory genes Proc. Natl. Acad. Sci. USA 106 2009 9373 9378
21. A.A. Chepurnov, M.N. Tuzova, V.A. Ternovoy, and I.V. Chernukhin Suppressive effect of Ebola virus on T cell proliferation in vitro is provided by a 125-kDa GP viral protein Immunol. Lett. 68 1999 257 261
22. J.J. Chiang, M.E. Davis, and M.U. Gack Regulation of RIG-I-like receptor signaling by host and viral proteins Cytokine Growth Factor Rev. 2014 10.1016/j.cytogfr.2014.06.005
23. C. Cilloniz, H. Ebihara, C. Ni, G. Neumann, M.J. Korth, S.M. Kelly, Y. Kawaoka, H. Feldmann, and M.G. Katze Functional genomics reveals the induction of inflammatory response and metalloproteinase gene expression during lethal Ebola virus infection J. Virol. 85 2011 9060 9068
24. M. Côté, J. Misasi, T. Ren, A. Bruchez, K. Lee, C.M. Filone, L. Hensley, Q. Li, D. Ory, K. Chandran, and J. Cunningham Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection Nature 477 2011 344 348
25. T.M. Desai, M. Marin, C.R. Chin, G. Savidis, A.L. Brass, and G.B. Melikyan IFITM3 restricts influenza A virus entry by blocking the formation of fusion pores following virus-endosome hemifusion PLoS Pathog. 10 2014 e1004048
26. D. Dube, M.B. Brecher, S.E. Delos, S.C. Rose, E.W. Park, K.L. Schornberg, J.H. Kuhn, and J.M. White The primed ebolavirus glycoprotein (19-kilodalton GP1,2): sequence and residues critical for host cell binding J. Virol. 83 2009 2883 2891
27. H. Ebihara, A. Takada, D. Kobasa, S. Jones, G. Neumann, S. Theriault, M. Bray, H. Feldmann, and Y. Kawaoka Molecular determinants of Ebola virus virulence in mice PLoS Pathog. 2 2006 e73
28. G. Fabozzi, C.S. Nabel, M.A. Dolan, and N.J. Sullivan Ebolavirus proteins suppress the effects of small interfering RNA by direct interaction with the mammalian RNA interference pathway J. Virol. 85 2011 2512 2523
29. Z. Feng, M. Cerveny, Z. Yan, and B. He The VP35 protein of Ebola virus inhibits the antiviral effect mediated by double-stranded RNA-dependent protein kinase PKR J. Virol. 81 2007 182 192
30. K. Gnirß, M. Fiedler, A. Krämer-Kühl, S. Bolduan, E. Mittler, S. Becker, M. Schindler, and S. Pöhlmann Analysis of determinants in filovirus glycoproteins required for tetherin antagonism Viruses 6 2014 1654 1671
31. A.M. Green, P.R. Beatty, A. Hadjilaou, and E. Harris Innate immunity to dengue virus infection and subversion of antiviral responses J. Mol. Biol. 426 2014 1148 1160 10.1016/j.jmb.2013.11.023
32. J. Haasnoot, W. de Vries, E.-J. Geutjes, M. Prins, P. de Haan, and B. Berkhout The Ebola virus VP35 protein is a suppressor of RNA silencing PLoS Pathog. 3 2007 e86
33. P. Halfmann, G. Neumann, and Y. Kawaoka The Ebolavirus VP24 protein blocks phosphorylation of p38 mitogen-activated protein kinase J. Infect. Dis. 204 Suppl 3 2011 S953 S956
34. S.C. Harrison Viral membrane fusion Nat. Struct. Mol. Biol. 15 2008 690 698
35. B. Hartlieb, J. Modrof, E. Mühlberger, H.-D. Klenk, and S. Becker Oligomerization of Ebola virus VP30 is essential for viral transcription and can be inhibited by a synthetic peptide J. Biol. Chem. 278 2003 41830 41836
36. B. Hartlieb, T. Muziol, W. Weissenhorn, and S. Becker Crystal structure of the C-terminal domain of Ebola virus VP30 reveals a role in transcription and nucleocapsid association Proc. Natl. Acad. Sci. USA 104 2007 624 629
37. A.L. Hartman, L. Ling, S.T. Nichol, and M.L. Hibberd Whole-genome expression profiling reveals that inhibition of host innate immune response pathways by Ebola virus can be reversed by a single amino acid change in the VP35 protein J. Virol. 82 2008 5348 5358
38. A.L. Hartman, B.H. Bird, J.S. Towner, Z.-A. Antoniadou, S.R. Zaki, and S.T. Nichol Inhibition of IRF-3 activation by VP35 is critical for the high level of virulence of ebola virus J. Virol. 82 2008 2699 2704
39. A.L. Hartman, J.S. Towner, and S.T. Nichol Ebola and marburg hemorrhagic fever Clin. Lab. Med. 30 2010 161 177
40. R.N. Harty, P.M. Pitha, and A. Okumura Antiviral activity of innate immune protein ISG15 J. Innate Immun. 1 2009 397 404
41. L.E. Hensley, S. Mulangu, C. Asiedu, J. Johnson, A.N. Honko, D. Stanley, G. Fabozzi, S.T. Nichol, T.G. Ksiazek, and P.E. Rollin Demonstration of cross-protective vaccine immunity against an emerging pathogenic Ebolavirus Species PLoS Pathog. 6 2010 e1000904
42. C.L. Hood, J. Abraham, J.C. Boyington, K. Leung, P.D. Kwong, and G.J. Nabel Biochemical and structural characterization of cathepsin L-processed Ebola virus glycoprotein: implications for viral entry and immunogenicity J. Virol. 84 2010 2972 2982
43. I.-C. Huang, C.C. Bailey, J.L. Weyer, S.R. Radoshitzky, M.M. Becker, J.J. Chiang, A.L. Brass, A.A. Ahmed, X. Chi, and L. Dong Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus PLoS Pathog. 7 2011 e1001258
44. C.L. Hunt, A.A. Kolokoltsov, R.A. Davey, and W. Maury The Tyro3 receptor kinase Axl enhances macropinocytosis of Zaire ebolavirus J. Virol. 85 2011 334 347
45. L.B. Ivashkiv, and L.T. Donlin Regulation of type I interferon responses Nat. Rev. Immunol. 14 2014 36 49
46. L.T. Jae, M. Raaben, A.S. Herbert, A.I. Kuehne, A.S. Wirchnianski, T.K. Soh, S.H. Stubbs, H. Janssen, M. Damme, and P. Saftig Virus entry. Lassa virus entry requires a trigger-induced receptor switch Science 344 2014 1506 1510
47. S. Jemielity, J.J. Wang, Y.K. Chan, A.A. Ahmed, W. Li, S. Monahan, X. Bu, M. Farzan, G.J. Freeman, and D.T. Umetsu TIM-family proteins promote infection of multiple enveloped viruses through virion-associated phosphatidylserine PLoS Pathog. 9 2013 e1003232
48. R.L. Kaletsky, J.R. Francica, C. Agrawal-Gamse, and P. Bates Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein Proc. Natl. Acad. Sci. USA 106 2009 2886 2891
49. C.R. Kimberlin, Z.A. Bornholdt, S. Li, V.L. Woods Jr., I.J. MacRae, and E.O. Saphire Ebolavirus VP35 uses a bimodal strategy to bind dsRNA for innate immune suppression Proc. Natl. Acad. Sci. USA 107 2010 314 319
50. A.L. Kindzelskii, Z. Yang, G.J. Nabel, R.F. Todd 3rd, and H.R. Petty Ebola virus secretory glycoprotein (sGP) diminishes Fc gamma RIIIB-to-CR3 proximity on neutrophils J. Immunol. 164 2000 953 958
51. T. Koma, C. Huang, O.A. Kolokoltsova, A.R. Brasier, and S. Paessler Innate immune response to arenaviral infection: a focus on the highly pathogenic New World hemorrhagic arenaviruses J. Mol. Biol. 425 2013 4893 4903
52. A.S. Kondratowicz, N.J. Lennemann, P.L. Sinn, R.A. Davey, C.L. Hunt, S. Moller-Tank, D.K. Meyerholz, P. Rennert, R.F. Mullins, and M. Brindley T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus Proc. Natl. Acad. Sci. USA 108 2011 8426 8431
53. T.G. Ksiazek, P.E. Rollin, A.J. Williams, D.S. Bressler, M.L. Martin, R. Swanepoel, F.J. Burt, P.A. Leman, A.S. Khan, and A.K. Rowe Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995 J. Infect. Dis. 179 Suppl 1 1999 S177 S187
54. A. Kühl, C. Banning, A. Marzi, J. Votteler, I. Steffen, S. Bertram, I. Glowacka, A. Konrad, M. Stürzl, and J.-T. Guo The Ebola virus glycoprotein and HIV-1 Vpu employ different strategies to counteract the antiviral factor tetherin J. Infect. Dis. 204 Suppl 3 2011 S850 S860
55. E.M. Leroy, S. Baize, V.E. Volchkov, S.P. Fisher-Hoch, M.C. Georges-Courbot, J. Lansoud-Soukate, M. Capron, P. Debré, J.B. McCormick, and A.J. Georges Human asymptomatic Ebola infection and strong inflammatory response Lancet 355 2000 2210 2215
56. E.M. Leroy, S. Baize, P. Debre, J. Lansoud-Soukate, and E. Mavoungou Early immune responses accompanying human asymptomatic Ebola infections Clin. Exp. Immunol. 124 2001 453 460
57. D.W. Leung, N.D. Ginder, D.B. Fulton, J. Nix, C.F. Basler, R.B. Honzatko, and G.K. Amarasinghe Structure of the Ebola VP35 interferon inhibitory domain Proc. Natl. Acad. Sci. USA 106 2009 411 416
58. D.W. Leung, K.C. Prins, D.M. Borek, M. Farahbakhsh, J.M. Tufariello, P. Ramanan, J.C. Nix, L.A. Helgeson, Z. Otwinowski, and R.B. Honzatko Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35 Nat. Struct. Mol. Biol. 17 2010 165 172
59. D.W. Leung, R.S. Shabman, M. Farahbakhsh, K.C. Prins, D.M. Borek, T. Wang, E. Mühlberger, C.F. Basler, and G.K. Amarasinghe Structural and functional characterization of Reston Ebola virus VP35 interferon inhibitory domain J. Mol. Biol. 399 2010 347 357
60. G. Lin, G. Simmons, S. Pöhlmann, F. Baribaud, H. Ni, G.J. Leslie, B.S. Haggarty, P. Bates, D. Weissman, J.A. Hoxie, and R.W. Doms Differential N-linked glycosylation of human immunodeficiency virus and Ebola virus envelope glycoproteins modulates interactions with DC-SIGN and DC-SIGNR J. Virol. 77 2003 1337 1346
61. Y. Liu, and R.N. Harty Viral and host proteins that modulate filovirus budding Future Virol. 5 2010 481 491
62. L.A. Lopez, S.J. Yang, H. Hauser, C.M. Exline, K.G. Haworth, J. Oldenburg, and P.M. Cannon Ebola virus glycoprotein counteracts BST-2/Tetherin restriction in a sequence-independent manner that does not require tetherin surface removal J. Virol. 84 2010 7243 7255
63. L.A. Lopez, S.J. Yang, C.M. Exline, S. Rengarajan, K.G. Haworth, and P.M. Cannon Anti-tetherin activities of HIV-1 Vpu and Ebola virus glycoprotein do not involve removal of tetherin from lipid rafts J. Virol. 86 2012 5467 5480
64. P. Luthra, P. Ramanan, C.E. Mire, C. Weisend, Y. Tsuda, B. Yen, G. Liu, D.W. Leung, T.W. Geisbert, and H. Ebihara Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome Cell Host Microbe 14 2013 74 84
65. S. Mahanty, K. Hutchinson, S. Agarwal, M. McRae, P.E. Rollin, and B. Pulendran Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses J. Immunol. 170 2003 2797 2801
66. M.J. Martinez, V.A. Volchkova, H. Raoul, N. Alazard-Dany, O. Reynard, and V.E. Volchkov Role of VP30 phosphorylation in the Ebola virus replication cycle J. Infect. Dis. 204 Suppl 3 2011 S934 S940
67. O. Martinez, L. Tantral, N. Mulherkar, K. Chandran, and C.F. Basler Impact of Ebola mucin-like domain on antiglycoprotein antibody responses induced by Ebola virus-like particles J. Infect. Dis. 204 Suppl 3 2011 S825 S832
68. O. Martinez, J.C. Johnson, A. Honko, B. Yen, R.S. Shabman, L.E. Hensley, G.G. Olinger, and C.F. Basler Ebola virus exploits a monocyte differentiation program to promote its entry J. Virol. 87 2013 3801 3814
69. M. Mateo, S.P. Reid, L.W. Leung, C.F. Basler, and V.E. Volchkov Ebolavirus VP24 binding to karyopherins is required for inhibition of interferon signaling J. Virol. 84 2010 1169 1175
70. M. Mateo, C. Carbonnelle, O. Reynard, L. Kolesnikova, K. Nemirov, A. Page, V.A. Volchkova, and V.E. Volchkov VP24 is a molecular determinant of Ebola virus virulence in guinea pigs J. Infect. Dis. 204 Suppl 3 2011 S1011 S1020
71. J. Mercer, and A. Helenius Vaccinia virus uses macropinocytosis and apoptotic mimicry to enter host cells Science 320 2008 531 535
72. T. Meyer, and U. Vinkemeier Nucleocytoplasmic shuttling of STAT transcription factors Eur. J. Biochem. 271 2004 4606 4612
73. E.H. Miller, G. Obernosterer, M. Raaben, A.S. Herbert, M.S. Deffieu, A. Krishnan, E. Ndungo, R.G. Sandesara, J.E. Carette, and A.I. Kuehne Ebola virus entry requires the host-programmed recognition of an intracellular receptor EMBO J. 31 2012 1947 1960
74. J. Misasi, K. Chandran, J.-Y. Yang, B. Considine, C.M. Filone, M. Côté, N. Sullivan, G. Fabozzi, L. Hensley, and J. Cunningham Filoviruses require endosomal cysteine proteases for entry but exhibit distinct protease preferences J. Virol. 86 2012 3284 3292
75. J. Modrof, S. Becker, and E. Mühlberger Ebola virus transcription activator VP30 is a zinc-binding protein J. Virol. 77 2003 3334 3338
76. G.S. Mohan, W. Li, L. Ye, R.W. Compans, and C. Yang Antigenic subversion: a novel mechanism of host immune evasion by Ebola virus PLoS Pathog. 8 2012 e1003065
77. S. Moller-Tank, A.S. Kondratowicz, R.A. Davey, P.D. Rennert, and W. Maury Role of the phosphatidylserine receptor TIM-1 in enveloped-virus entry J. Virol. 87 2013 8327 8341
78. K. Morizono, and I.S.Y. Chen Role of phosphatidylserine receptors in enveloped virus infection J. Virol. 88 2014 4275 4290
79. E. Mühlberger, M. Weik, V.E. Volchkov, H.D. Klenk, and S. Becker Comparison of the transcription and replication strategies of marburg virus and Ebola virus by using artificial replication systems J. Virol. 73 1999 2333 2342
80. N. Mulherkar, M. Raaben, J.C. de la Torre, S.P. Whelan, and K. Chandran The Ebola virus glycoprotein mediates entry via a non-classical dynamin-dependent macropinocytic pathway Virology 419 2011 72 83
81. A. Nanbo, M. Imai, S. Watanabe, T. Noda, K. Takahashi, G. Neumann, P. Halfmann, and Y. Kawaoka Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner PLoS Pathog. 6 2010 e1001121
82. S.J.D. Neil, T. Zang, and P.D. Bieniasz Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu Nature 451 2008 425 430
83. S. Noisakran, S. Sengsai, V. Thongboonkerd, R. Kanlaya, S. Sinchaikul, S.-T. Chen, C. Puttikhunt, W. Kasinrerk, T. Limjindaporn, and W. Wongwiwat Identification of human hnRNP C1/C2 as a dengue virus NS1-interacting protein Biochem. Biophys. Res. Commun. 372 2008 67 72
84. J.M. Perreira, C.R. Chin, E.M. Feeley, and A.L. Brass IFITMs restrict the replication of multiple pathogenic viruses J. Mol. Biol. 425 2013 4937 4955
85. E.L. Pettit Kneller, J.H. Connor, and D.S. Lyles hnRNPs Relocalize to the cytoplasm following infection with vesicular stomatitis virus J. Virol. 83 2009 770 780
86. L.C. Platanias Mechanisms of type-I- and type-II-interferon-mediated signalling Nat. Rev. Immunol. 5 2005 375 386
87. K.C. Prins, W.B. Cárdenas, and C.F. Basler Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKKepsilon and TBK-1 J. Virol. 83 2009 3069 3077
88. K.C. Prins, S. Delpeut, D.W. Leung, O. Reynard, V.A. Volchkova, S.P. Reid, P. Ramanan, W.B. Cárdenas, G.K. Amarasinghe, V.E. Volchkov, and C.F. Basler Mutations abrogating VP35 interaction with double-stranded RNA render Ebola virus avirulent in guinea pigs J. Virol. 84 2010 3004 3015
89. K. Quinn, M.A. Brindley, M.L. Weller, N. Kaludov, A. Kondratowicz, C.L. Hunt, P.L. Sinn, P.B. McCray Jr., C.S. Stein, and B.L. Davidson Rho GTPases modulate entry of Ebola virus and vesicular stomatitis virus pseudotyped vectors J. Virol. 83 2009 10176 10186
90. S.P. Reid, L.W. Leung, A.L. Hartman, O. Martinez, M.L. Shaw, C. Carbonnelle, V.E. Volchkov, S.T. Nichol, and C.F. Basler Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation J. Virol. 80 2006 5156 5167
91. S.P. Reid, C. Valmas, O. Martinez, F.M. Sanchez, and C.F. Basler Ebola virus VP24 proteins inhibit the interaction of NPI-1 subfamily karyopherin alpha proteins with activated STAT1 J. Virol. 81 2007 13469 13477
92. M.F. Saeed, A.A. Kolokoltsov, T. Albrecht, and R.A. Davey Cellular entry of ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes PLoS Pathog. 6 2010 e1001110
93. A. Sanchez, M.P. Kiley, B.P. Holloway, and D.D. Auperin Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus Virus Res. 29 1993 215 240
94. A.A.J. Sanchez, M. Lukwiya, D. Bausch, S. Mahanty, A.J. Sanchez, K.D. Wagoner, and P.E. Rollin Analysis of human peripheral blood samples from fatal and nonfatal cases of Ebola (Sudan) hemorrhagic fever: cellular responses, virus load, and nitric oxide levels J. Virol. 78 2004 10370 10377
95. A. Sanchez, and M.P. Kiley Identification and analysis of Ebola virus messenger RNA Virology 157 1987 414 420
96. K. Schornberg, S. Matsuyama, K. Kabsch, S. Delos, A. Bouton, and J. White Role of endosomal cathepsins in entry mediated by the Ebola virus glycoprotein J. Virol. 80 2006 4174 4178
97. K.L. Schornberg, C.J. Shoemaker, D. Dube, M.Y. Abshire, S.E. Delos, A.H. Bouton, and J.M. White Alpha5beta1-integrin controls ebolavirus entry by regulating endosomal cathepsins Proc. Natl. Acad. Sci. USA 106 2009 8003 8008
98. M. Schümann, T. Gantke, and E. Mühlberger Ebola virus VP35 antagonizes PKR activity through its C-terminal interferon inhibitory domain J. Virol. 83 2009 8993 8997
99. R.S. Shabman, E.E. Gulcicek, K.L. Stone, and C.F. Basler The Ebola virus VP24 protein prevents hnRNP C1/C2 binding to karyopherin α1 and partially alters its nuclear import J. Infect. Dis. 204 Suppl 3 2011 S904 S910
100. M. Shimojima, A. Takada, H. Ebihara, G. Neumann, K. Fujioka, T. Irimura, S. Jones, H. Feldmann, and Y. Kawaoka Tyro3 family-mediated cell entry of Ebola and Marburg viruses J. Virol. 80 2006 10109 10116
101. M. Shimojima, Y. Ikeda, and Y. Kawaoka The mechanism of Axl-mediated Ebola virus infection J. Infect. Dis. 196 Suppl 2 2007 S259 S263
102. G. Simmons, J.D. Reeves, C.C. Grogan, L.H. Vandenberghe, F. Baribaud, J.C. Whitbeck, E. Burke, M.J. Buchmeier, E.J. Soilleux, and J.L. Riley DC-SIGN and DC-SIGNR bind ebola glycoproteins and enhance infection of macrophages and endothelial cells Virology 305 2003 115 123
103. R.V. Stahelin Membrane binding and bending in Ebola VP40 assembly and egress Front. Microbiol. 5 2014 300
104. D.A. Stanley, A.N. Honko, C. Asiedu, J.C. Trefry, A.W. Lau-Kilby, J.C. Johnson, L. Hensley, V. Ammendola, A. Abbate, and F. Grazioli Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge Nat. Med. 2014 10.1038/nm.3702 Published online September 7, 2014
105. N.J. Sullivan, L. Hensley, C. Asiedu, T.W. Geisbert, D. Stanley, J. Johnson, A. Honko, G. Olinger, M. Bailey, and J.B. Geisbert CD8+ cellular immunity mediates rAd5 vaccine protection against Ebola virus infection of nonhuman primates Nat. Med. 17 2011 1128 1131
106. A. Takada, S. Watanabe, H. Ito, K. Okazaki, H. Kida, and Y. Kawaoka Downregulation of beta1 integrins by Ebola virus glycoprotein: implication for virus entry Virology 278 2000 20 26
107. V.E. Volchkov, V.M. Blinov, and S.V. Netesov The envelope glycoprotein of Ebola virus contains an immunosuppressive-like domain similar to oncogenic retroviruses FEBS Lett. 305 1992 181 184
108. V.A. Volchkova, O. Dolnik, M.J. Martinez, O. Reynard, and V.E. Volchkov Genomic RNA editing and its impact on Ebola virus adaptation during serial passages in cell culture and infection of guinea pigs J. Infect. Dis. 204 Suppl 3 2011 S941 S946
109. N. Wauquier, P. Becquart, C. Padilla, S. Baize, and E.M. Leroy Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis PLoS Negl. Trop. Dis. 4 2010 4
110. Z. Wen, B. Zhao, K. Song, X. Hu, W. Chen, D. Kong, J. Ge, and Z. Bu Recombinant lentogenic Newcastle disease virus expressing Ebola virus GP infects cells independently of exogenous trypsin and uses macropinocytosis as the major pathway for cell entry Virol. J. 10 2013 331
111. P. Wimmer, S. Schreiner, and T. Dobner Human pathogens and the host cell SUMOylation system J. Virol. 86 2012 642 654
112. G. Wong, J.S. Richardson, S. Pillet, A. Patel, X. Qiu, J. Alimonti, J. Hogan, Y. Zhang, A. Takada, and H. Feldmann Immune parameters correlate with protection against ebola virus infection in rodents and nonhuman primates Sci. Transl. Med. 4 2012 158ra146
113. R.J. Wool-Lewis, and P. Bates Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines J. Virol. 72 1998 3155 3160
114. W. Xu, M.R.R. Edwards, D.M.M. Borek, A.R.R. Feagins, A. Mittal, J.B.B. Alinger, K.N.N. Berry, B. Yen, J. Hamilton, and T.J.J. Brett Ebola virus VP24 targets a unique NLS binding site on karyopherin alpha 5 to selectively compete with nuclear import of phosphorylated STAT1 Cell Host Microbe 16 2014 187 200
115. K. Yaddanapudi, G. Palacios, J.S. Towner, I. Chen, C.A. Sariol, S.T. Nichol, and W.I. Lipkin Implication of a retrovirus-like glycoprotein peptide in the immunopathogenesis of Ebola and Marburg viruses FASEB J. 20 2006 2519 2530
116. Z. Yang, R. Delgado, L. Xu, R.F. Todd, E.G. Nabel, A. Sanchez, and G.J. Nabel Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins Science 279 1998 1034 1037
117. Z.Y. Yang, H.J. Duckers, N.J. Sullivan, A. Sanchez, E.G. Nabel, and G.J. Nabel Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury Nat. Med. 6 2000 886 889
118. A. Zachowski Phospholipids in animal eukaryotic membranes: transverse asymmetry and movement Biochem. J. 294 1993 1 14
119. A. Zagórska, P.G. Través, E.D. Lew, I. Dransfield, and G. Lemke Diversification of TAM receptor tyrosine kinase function Nat. Immunol. 15 2014 920 928
120. A.P.P. Zhang, Z.A. Bornholdt, T. Liu, D.M. Abelson, D.E. Lee, S. Li, V.L. Woods Jr., and E.O. Saphire The ebola virus interferon antagonist VP24 directly binds STAT1 and has a novel, pyramidal fold PLoS Pathog. 8 2012 e1002550
121. Y. Zhu, N.C. Cherukuri, J.N. Jackel, Z. Wu, M. Crary, K.J. Buckley, D.M. Bisaro, and D.S. Parris Characterization of the RNA silencing suppression activity of the Ebola virus VP35 protein in plants and mammalian cells J. Virol. 86 2012 3038 3049